Evaluation of WLBU2 peptide and 3-O-octyl-sn-glycerol lipid as active ingredients for a topical microbicide formulation targeting Chlamydia trachomatis

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 2, 2010, Pages 627-636

  Skinner, M C ^a   Kiselev, A O ^a   Isaacs, C E ^b   Mietzner, T A ^c   Montelaro, R C ^c,d   Lampe, M F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 3 O OCTYL SN GLYCEROL; ANTIINFECTIVE AGENT; ANTIMICROBIAL PEPTIDE WLBU2; HUMAN SERUM ALBUMIN; LACTATE DEHYDROGENASE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL TRANSMISSION; CHLAMYDIA TRACHOMATIS; CYTOTOXICITY; DRUG ACTIVITY; DRUG POTENTIATION; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; SEMINAL PLASMA; VAGINA DISCHARGE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; CHLAMYDIA TRACHOMATIS; DRUG SYNERGISM; FEMALE; GLYCERYL ETHERS; HUMANS; HYDROGEN-ION CONCENTRATION; L-LACTATE DEHYDROGENASE; MALE; MICE; MICROBIAL SENSITIVITY TESTS; PENICILLIN G; POLYMYXIN B; TETRAZOLIUM SALTS; THIAZOLES;

EID: 75749137270     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00635-09     Document Type: Article

References (50)

1. Ballweber, L. M., J. E. Jaynes, W. E. Stamm, and M. F. Lampe. 2002. In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis. Antimicrob. Agents Chemother. 46:34-41.
2. Berman, S. M., and M. S. Cohen. 2006. STD treatment: how can it improve HIV prevention in the South? Sex. Transm. Dis. 33:S50-S57.
3. Bliss, C. I., and D. F. Mexico. 1939. The toxicity of poisons applied jointly. Ann. Appl. Biol. 26:585-615.
4. Buck, C. B., C. D. Thompson, J. N. Roberts, M. Müller, D. R. Lowy, and J. T. Schiller. 2006. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog. 2:e69.
5. CDC. 2009. Sexually transmitted disease surveillance, 2007. Department of Health and Human Services, Atlanta, GA.
6. Cohen, J. 2009. Retrovirus meeting. HIV/AIDS researchers reach for highhanging fruit. Science 323:996-997.
7. Deslouches, B., I. A. Gonzalez, D. DeAlmeida, K. Islam, C. Steele, R. C. Montelaro, and T. A. Mietzner. 2007. De novo-derived cationic antimicrobial peptide activity in a murine model of Pseudomonas aeruginosa bacteraemia. J. Antimicrob. Chemother. 60:669-672.
8. Deslouches, B., K. Islam, J. K. Craigo, S. M. Paranjape, R. C. Montelaro, and T. A. Mietzner. 2005. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob. Agents Chemother. 49:3208-3216.
9. Deslouches, B., S. M. Phadke, V. Lazarevic, M. Cascio, K. Islam, R. C. Montelaro, and T. A. Mietzner. 2005. De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity. Antimicrob. Agents Chemother. 49:316-322.
10. Fichorova, R. N., L. D. Tucker, and D. J. Anderson. 2001. The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J. Infect. Dis. 184: 418-428.
11. Fleming, D. T., and J. N. Wasserheit. 1999. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex. Transm. Infect. 75:3-17.
12. Fletcher, P., S. Harman, H. Azijn, N. Armanasco, P. Manlow, D. Perumal, M.-P. de Bethune, J. Nuttall, J. Romano, and R. Shattock. 2009. Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor. Antimicrob. Agents Chemother. 53:487-495.
13. Galvin, S. R., and M. S. Cohen. 2004. The role of sexually transmitted diseases in HIV transmission. Nat. Rev. Microbiol. 2:33-42.
14. Gong, E., B. Matthews, T. McCarthy, J. Chu, G. Holan, J. Raff, and S. Sacks. 2005. Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. Antiviral Res. 68:139-146.
15. Gupta, K. M., S. R. Barnes, R. A. Tangaro, M. C. Roberts, D. H. Owen, D. F. Katz, and P. F. Kiser. 2007. Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles. J. Pharm. Sci. 96:670-681.
16. Hancock, R. E., and A. Rozek. 2002. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol. Lett. 206:143-149.
17. Hancock, R. E. W. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet i:156-164.
18. Isaacs, C. E. 2001. The antimicrobial function of milk lipids. Adv. Nutr. Res. 10:271-285.
19. Isaacs, C. E., J. H. Jia, and W. Xu. 2004. A lipid-peptide microbicide inactivates herpes simplex virus. Antimicrob. Agents Chemother. 48:3182-3184.
20. Isaacs, C. E., K. S. Kim, and H. Thormar. 1994. Inactivation of enveloped viruses in human bodily fluids by purified lipids. Ann. N. Y. Acad. Sci. 724:457-464.
21. Isaacs, C. E., R. E. Litov, and H. Thormar. 1995. Antimicrobial activity of lipids added to human milk, infant formula, and bovine milk. Nutr. Biochem. 6:362-366.
22. Isaacs, C. E., L. Rohan, W. Xu, J. H. Jia, T. Mietzner, and S. Hillier. 2006. Inactivation of herpes simplex virus clinical isolates by using a combination microbicide. Antimicrob. Agents Chemother. 50:1063-1066.
23. Isaacs, C. E., and H. Thormar. 1991. The role of milk-derived antimicrobial lipids as antiviral and antibacterial agents. Adv. Exp. Med. Biol. 310:159-165.
24. Krishnan, M. Y., E. J. Manning, and M. T. Collins. 2009. Effects of interactions of antibacterial drugs with each other and with 6-mercaptopurine on in vitro growth of Mycobacterium avium subspecies paratuberculosis. J. Antimicrob. Chemother. 64:1018-1023.
25. Lai, B. E., Y. Q. Xie, M. L. Lavine, A. J. Szeri, D. H. Owen, and D. F. Katz. 2008. Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow. J. Pharm. Sci. 97:1030-1038.
26. Lampe, M. F., L. M. Ballweber, C. E. Isaacs, D. L. Patton, and W. E. Stamm. 1998. Killing of Chlamydia trachomatis by novel antimicrobial lipids adapted from compounds in human breast milk. Antimicrob. Agents Chemother. 42:1239-1244.
27. Li, Q., J. D. Estes, P. M. Schlievert, L. Duan, A. J. Brosnahan, P. J. Southern, C. S. Reilly, M. L. Peterson, N. Schultz-Darken, K. G. Brunner, K. R. Nephew, S. Pambuccian, J. D. Lifson, J. V. Carlis, and A. T. Haase. 2009. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458:1034-1038.
28. Madan, R. P., M. J. Keller, and B. C. Herold. 2006. Prioritizing prevention of HIV and sexually transmitted infections: first-generation vaginal microbicides. Curr. Opin. Infect. Dis. 19:49-54.
29. McCarthy, T. D., P. Karellas, S. A. Henderson, M. Giannis, D. F. O'Keefe, G. Heery, J. R. A. Paull, B. R. Matthews, and G. Holan. 2009. Dendrimers as drugs: discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention. Mol. Pharm. 2:312-318.
30. Moncla, B. J., K. Pryke, and C. E. Isaacs. 2008. Killing of Neisseria gonorrhoeae, Streptococcus agalactiae (group B Streptococcus), Haemophilus ducreyi, and vaginal Lactobacillus by 3-O-octyl-sn-glycerol. Antimicrob. Agents Chemother. 52:1577-1579.
31. Novak, K. F., W. J. Diamond, S. Kirakodu, R. Peyyala, K. W. Anderson, R. C. Montelaro, and T. A. Mietzner. 2007. Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria. Antimicrob. Agents Chemother. 51:1837-1839.
32. Owen, D. H., and D. F. Katz. 2005. A review of the physical and chemical properties of human semen and the formulation of a semen simulant. J. Androl. 26:459-469.
33. Owen, D. H., and D. F. Katz. 1999. A vaginal fluid simulant. Contraception 59:91-95.
34. Sassi, A. B., C. E. Isaacs, B. J. Moncla, P. Gupta, S. Hillier, and L. C. Rohan. 2008. Effects of physiological fluids on physical-chemical characteristics and activity of topical vaginal microbicide products. J. Pharm. Sci. 97:3123-3139.
35. Schlievert, P. M., K. L. Strandberg, A. J. Brosnahan, M. L. Peterson, S. E. Pambuccian, K. R. Nephew, K. G. Brunner, N. J. Schultz-Darken, and A. T. Haase. 2008. Glycerol monolaurate does not alter rhesus macaque (Macaca mulatta) vaginal lactobacilli and is safe for chronic use. Antimicrob. Agents Chemother. 52:4448-4454.
36. Scordi-Bello, I. A., A. Mosoian, C. He, Y. Chen, Y. Cheng, G. A. Jarvis, M. J. Keller, K. Hogarty, D. P. Waller, A. T. Profy, B. C. Herold, and M. E. Klotman. 2005. Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action. Antimicrob. Agents Chemother. 49:3607-3615.
37. Skoler-Karpoff, S., G. Ramjee, K. Ahmed, L. Altini, M. G. Plagianos, B. Friedland, S. Govender, A. De Kock, N. Cassim, T. Palanee, G. Dozier, R. Maguire, and P. Lahteenmaki. 2008. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 372:1977-1987.
38. Suchland, R. J., and W. E. Stamm. 1991. Simplified microtiter cell culture method for rapid immunotyping of Chlamydia trachomatis. J. Clin. Microbiol. 29:1333-1338.
39. Tao, W., C. Richards, and D. Hamer. 2008. Enhancement of HIV infection by cellulose sulfate. AIDS Res. Hum. Retroviruses 24:925-929.
40. Teleshova, N., T. Chang, A. Profy, and M. E. Klotman. 2008. Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell-mediated human immunodeficiency virus transfer. Antimicrob. Agents Chemother. 52:1751-1758.
41. Tevi-Bénissan, C., L. Bélec, M. Lévy, V. Schneider-Fauveau, A. S. Mohamed, M. C. Hallouin, M. Matta, and G. Grésenguet. 1997. In vivo semen-associated pH neutralization of cervicovaginal secretions. Clin. Diagn. Lab. Immunol. 4:367-374.
42. Van Damme, L., R. Govinden, F. M. Mirembe, F. Guédou, S. Solomon, M. L. Becker, B. S. Pradeep, A. K. Krishnan, M. Alary, B. Pande, G. Ramjee, J. Deese, T. Crucitti, D. Taylor, and the C. S. Study Group. 2008. Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl. J. Med. 359:463-472.
43. Van Damme, L., G. Ramjee, M. Alary, B. Vuylsteke, V. Chandeying, H. Rees, P. Sirivongrangson, L. Mukenge-Tshibaka, V. Ettiègne-Traoré, C. Uaheowitchai, S. S. Karim, B. Mâsse, J. Perriëns, and M. Laga. 2002. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 360:971-977.
44. Van Kuppeveld, F. J. M., K. E. Johansson, J. M. D. Galama, J. Kissing, G. Bölske, J. T. M. Van Der Logt, and W. J. G. Melchers. 1994. Detection of mycoplasma contamination in cell cultures by a mycoplasma group-specific PCR. Appl. Environ. Microbiol. 60:149-152.
45. Van Kuppeveld, F. J. M., J. T. M. Van Der Logt, A. F. Angulo, M. J. Van Zoest, W. G. V. Quint, H. G. M. Niesters, J. M. D. Galama, and W. J. G. Melchers. 1992. Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification. Appl. Environ. Microbiol. 58:2606-2615.
46. Wasserheit, J. N. 1992. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Transm. Dis. 19:61-77.
47. Wu, J. C. F., and M. Hamada. 2000. Experiments: planning, analysis, and parameter design optimization. J. Wiley & Sons, Inc., New York, NY.
48. Yasin, B., M. Pang, R. I. Lehrer, and E. A. Wagar. 2003. Activity of Novispirin G-10, a novel antimicrobial peptide against Chlamydia trachomatis and vaginosis-associated bacteria. Exp. Mol. Pathol. 74:190-195.
49. Yasin, B., M. Pang, R. I. Lehrer, and E. A. Wagar. 2004. A cumulative experience examining the effect of natural and synthetic antimicrobial peptides vs. Chlamydia trachomatis. J. Pept. Res. 64:65-71.
50. Yasin, B., M. Pang, E. A. Wagar, and R. I. Lehrer. 2002. Examination of Chlamydia trachomatis infection in environments mimicking normal and abnormal vaginal pH. Sex. Transm. Dis. 29:514-519.